Found: 25
Select item for more details and to access through your institution.
Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
- Published in:
- Genome Medicine, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13073-019-0669-z
- By:
- Publication type:
- Article
Synthesis of Carboxamide‐Containing Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors Targeting Acute Myeloid Leukemia.
- Published in:
- ChemMedChem, 2021, v. 16, n. 8, p. 1316, doi. 10.1002/cmdc.202000754
- By:
- Publication type:
- Article
A Phase I Clinical Trial of Irinotecan and Carboplatin in Patients with Extensive Stage Small Cell Lung Cancer.
- Published in:
- Chemotherapy (0009-3157), 2012, v. 58, n. 4, p. 257, doi. 10.1159/000341274
- By:
- Publication type:
- Article
Systemic Treatment-Decision Algorithms in Muscle-Invasive Bladder Cancer: Clinical Complexities and Navigating for Improved Outcomes.
- Published in:
- Research & Reports in Urology, 2023, v. 15, p. 321, doi. 10.2147/RRU.S386549
- By:
- Publication type:
- Article
Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 6, p. 897, doi. 10.1038/s41416-023-02543-0
- By:
- Publication type:
- Article
Epigenetic modulators as therapeutic targets in prostate cancer.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0264-8
- By:
- Publication type:
- Article
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease.
- Published in:
- Oncologist, 2021, v. 26, n. 12, p. 1026, doi. 10.1002/onco.13925
- By:
- Publication type:
- Article
Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 8, p. 3800, doi. 10.1002/cam4.1594
- By:
- Publication type:
- Article
Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 1, p. 186, doi. 10.1002/cam4.986
- By:
- Publication type:
- Article
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 1, p. 138, doi. 10.3390/diagnostics11010138
- By:
- Publication type:
- Article
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 4, p. 491, doi. 10.1080/0284186X.2017.1369565
- By:
- Publication type:
- Article
The latest treatment options for bladder cancer.
- Published in:
- British Medical Bulletin, 2018, v. 128, n. 1, p. 85, doi. 10.1093/bmb/ldy034
- By:
- Publication type:
- Article
Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2586, doi. 10.1002/cncr.29387
- By:
- Publication type:
- Article
BAG-1 in carcinogenesis.
- Published in:
- Expert Reviews in Molecular Medicine, 2004, v. 6, n. 7, p. 1, doi. 10.1017/S1462399404007537
- By:
- Publication type:
- Article
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00463
- By:
- Publication type:
- Article
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 9, p. 2961, doi. 10.1007/s00262-023-03469-5
- By:
- Publication type:
- Article
Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 84, doi. 10.3390/cancers12010084
- By:
- Publication type:
- Article
Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer.
- Published in:
- Clinical Cancer Update, 2008, v. 2, n. 1, p. 28, doi. 10.3816/CCU.2008.n.005
- By:
- Publication type:
- Article
LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models.
- Published in:
- Cancer Cell International, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12935-018-0568-1
- By:
- Publication type:
- Article
Is Triple Therapy the New Standard for Metastatic Hormone-sensitive Prostate Cancer?
- Published in:
- touchREVIEWS in Oncology & Haematology, 2022, v. 18, n. 2, p. 120, doi. 10.17925/OHR.2022.18.2.120
- By:
- Publication type:
- Article
Clinical characteristics and outcomes for patients with non‑metastatic castration-resistant prostate cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-01042-7
- By:
- Publication type:
- Article
Orteronel Switch Maintenance Therapy in Metastatic Castration Resistant Prostate Cancer After First-Line Docetaxel: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial (SAKK 08/11).
- Published in:
- Prostate, 2016, v. 76, n. 16, p. 1519, doi. 10.1002/pros.23236
- By:
- Publication type:
- Article
Loss of expression of the tumour suppressor gene AIMP3 predicts survival following radiotherapy in muscle-invasive bladder cancer.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 3, p. 709, doi. 10.1002/ijc.29022
- By:
- Publication type:
- Article
Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158952
- By:
- Publication type:
- Article